Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HSH2D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | GNPTAB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | FAM229B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TIAM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZNF607 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MT1HL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | COX10 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ISG20L2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | C17orf74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |